Cargando…

Management of Children and Adolescents with Wilson Disease and Neurological Worsening Following D–Penicillamine Therapy: A Single Centre Experience

BACKGROUND: Most centers in developing countries prefer chelation therapy with D-penicillamine for the management of Wilson's disease (WD) because of its easy availability and affordability. Neurological worsening following treatment with D-penicillamine is not uncommon. However, there is a pau...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumar, Madhan, Murugan, T. P, Lionel, Arul P., Thomas, Maya M., Mannam, Pavithra, Yoganathan, Sangeetha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540946/ https://www.ncbi.nlm.nih.gov/pubmed/36211139 http://dx.doi.org/10.4103/aian.aian_519_21

Ejemplares similares

Combined dimercaptosuccinic acid and zinc treatment in neurological Wilson’s disease patients with penicillamine-induced allergy or early neurological deterioration
por: Zhu, Xiao-Qun, et al.
Publicado: (2020)

Combined sodium Dimercaptopropanesulfonate and zinc versus D-penicillamine as first-line therapy for neurological Wilson’s disease
por: Zhang, Jing, et al.
Publicado: (2020)

Pompholyx-Like Eruptions Induced by Penicillamine in a Patient with Wilson's Disease
por: Devassy, Diana Elizabeth, et al.
Publicado: (2019)

D-penicillamine in Wilson's disease; recognizing the transition from benefit to harm
por: Goh, Yihui, et al.
Publicado: (2021)

Clinical and Genetic Analysis in Neurological Wilson’s Disease Patients With Neurological Worsening Following Chelator Therapy
por: Hou, Haiman, et al.
Publicado: (2022)

A rare case of DIC in a patient with Wilson’s disease: D-penicillamine
por: Emre Parlar, Yavuz, et al.
Publicado: (2022)

D-penicillamine Induced Myasthenia Gravis in Wilson’s Disease: A Case Report
por: Thapa, Lekhjung, et al.
Publicado: (2022)

Evaluation of vitamin B(6) supplementation in Wilson’s disease patients treated with D-penicillamine
por: Mbala, Justin, et al.
Publicado: (2023)

Elastosis Perforans Serpiginosa: a D-penicillamine induced dermatoses in a patient with Wilson’s disease
por: Samal, Swagatika, et al.
Publicado: (2020)

Long-term effects of a combination of D-penicillamine and zinc salts in the treatment of Wilson’s disease in children
por: CHANG, HONG, et al.
Publicado: (2013)

Chemosensitivity of U251 Cells to the Co-treatment of D-Penicillamine and Copper: Possible Implications on Wilson Disease Patients
por: Katerji, Meghri, et al.
Publicado: (2017)

D-PENICILLAMINE INDUCED ELASTOSIS PERFORANS SERPIGINOSA MIMICKING ACNE KELOIDALIS NUCHAE
por: Pavithra, S, et al.
Publicado: (2011)

Hereditary Folate Malabsorption: A Rare Treatable Disorder with Hematological and Neurological Manifestations
por: Kumar, Madhan, et al.
Publicado: (2022)

Penicillamine Neurotoxicity: An Hypothesis
por: Walshe, J. M.
Publicado: (2011)

Historical Perspectives of Penicillamine
por: Fernandes, Luke, et al.
Publicado: (1980)

Treatment with d-penicillamine or zinc sulphate affects copper metabolism and improves but not normalizes antioxidant capacity parameters in Wilson disease
por: Grażyna, Gromadzka, et al.
Publicado: (2013)

D-penicillamine-induced membranous nephropathy
por: Kumar, R. P. Senthil, et al.
Publicado: (2014)

Erratum to: Treatment with d-penicillamine or zinc sulphate affects copper metabolism and improves but not normalizes antioxidant capacity parameters in Wilson disease
por: Gromadzka, Grażyna, et al.
Publicado: (2014)

Comparison of the Effectiveness and Safety of d-Penicillamine and Zinc Salt Treatment for Symptomatic Wilson Disease: A Systematic Review and Meta‐Analysis
por: Tang, Shan, et al.
Publicado: (2022)

D-Penicillamine-Induced Myasthenia Gravis—A Probable Complication of Wilson’s Disease Treatment—A Case Report and Systematic Review of the Literature
por: Antos, Agnieszka, et al.
Publicado: (2023)

D-penicillamine Induced Degenerative Dermopathy
por: Khandpur, Sujay, et al.
Publicado: (2015)

Gold salts, D-penicillamine and allopurinol
por: Ueda, Shiro, et al.
Publicado: (2008)

D-penicillamine-induced Elastosis Perforans Serpiginosa
por: Yao, Xue-Yan, et al.
Publicado: (2017)

Neurodegeneration in Hepatic and Neurologic Wilson’s Disease
por: Viveiros, André, et al.
Publicado: (2021)

Neurological Phenotype of Mowat-Wilson Syndrome
por: Cordelli, Duccio Maria, et al.
Publicado: (2021)

Oculodigital Sign: A Clinical Clue for Diagnosis
por: Yoganathan, Sangeetha, et al.
Publicado: (2022)

The use of D-penicillamine in cystinuria: efficacy and untoward reactions.
por: Halperin, E. C., et al.
Publicado: (1981)

Crystal structure of S,N-dibenzyl-d-penicillamine monohydrate
por: Yoshinari, Nobuto, et al.
Publicado: (2014)

Clinical Profile, Prognostic Indicators, and Therapeutic Outcomes of Pediatric Opsoclonus-Myoclonus-Ataxia Syndrome: A Single-Center Experience from South India
por: Muthusamy, Karthik, et al.
Publicado: (2019)

GanDouLing combined with Penicillamine improves cerebrovascular injury via PERK/eIF2α/CHOP endoplasmic reticulum stress pathway in the mouse model of Wilson’s disease
por: Chen, Yonghua, et al.
Publicado: (2018)

D-penicillamine-induced glomerulonephritis with crescent formation: Remission following drug discontinuation
por: Mokuda, S., et al.
Publicado: (2013)

Protective Effects of D-Penicillamine on Catecholamine-Induced Myocardial Injury
por: Říha, Michal, et al.
Publicado: (2016)

Penicillamine-induced elastosis perforans serpiginosa and pseudo-pseudoxanthoma elasticum
por: Heusinkveld, Lauren E., et al.
Publicado: (2021)

Characteristics of neurological Wilson’s disease with corpus callosum abnormalities
por: Zhou, Zhi-Hua, et al.
Publicado: (2019)

Predictors of caregiver burden in patients with neurologic Wilson disease
por: Wu, Peng, et al.
Publicado: (2020)

Emerging neurological symptoms after liver transplantation: A 6‐year follow‐up of an adolescent patient with Wilson’s disease
por: Xu, Wan‐Qing, et al.
Publicado: (2022)

Maternal Cigarette Smoke Exposure Worsens Neurological Outcomes in Adolescent Offspring with Hypoxic-Ischemic Injury
por: Chan, Yik L., et al.
Publicado: (2017)

ANCA-associated Goodpasture's syndrome in a patient with rheumatoid arthritis on penicillamine
por: Sharma, R., et al.
Publicado: (2012)

Pemphigus Vulgaris Associated with Rheumatoid Arthritis in a Patient not Taking Penicillamine
por: Gholizadeh, Narges, et al.
Publicado: (2012)

Lead(II) Binding to the Chelating Agent d-Penicillamine in Aqueous Solution
por: Sisombath, Natalie S., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ff4bb58gqgm7i2dlmeg7ol6824